Clearbridge Investments, LLC Charles River Laboratories International, Inc. Transaction History

Clearbridge Investments, LLC

$123 Billion
Q3 2024

A detailed history of Clearbridge Investments, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Clearbridge Investments, LLC holds 1,090,992 shares of CRL stock, worth $203 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

1,090,992

Previous 1,368,505 20.28%

Holding current value

$203 Million

Previous $283 Million 23.98%

% of portfolio

0.18%

Previous 0.24%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$187.96 - $245.29 $52.2 Million - $68.1 Million	-277,513 Reduced 20.28%	1,090,992 $215 Million
Q2 2024 Aug 14, 2024	SELL	$206.39 - $268.73 $29.9 Million - $38.9 Million	-144,633 Reduced 9.56%	1,368,505 $283 Million
Q1 2024 May 13, 2024	BUY	$203.52 - $273.43 $9.17 Million - $12.3 Million	45,079 Added 3.07%	1,513,138 $410 Million
Q4 2023 Feb 09, 2024	SELL	$164.52 - $238.84 $45.7 Million - $66.4 Million	-277,935 Reduced 15.92%	1,468,059 $347 Million
Q3 2023 Nov 13, 2023	SELL	$194.44 - $217.61 $800,315 - $895,682	-4,116 Reduced 0.24%	1,745,994 $342 Million
Q2 2023 Aug 11, 2023	BUY	$183.71 - $210.25 $63 Million - $72.1 Million	343,076 Added 24.38%	1,750,110 $368 Million
Q1 2023 May 12, 2023	BUY	$191.89 - $259.92 $6.94 Million - $9.4 Million	36,176 Added 2.64%	1,407,034 $284 Million
Q4 2022 Feb 10, 2023	SELL	$197.11 - $250.07 $15.5 Million - $19.7 Million	-78,671 Reduced 5.43%	1,370,858 $299 Million
Q3 2022 Nov 14, 2022	SELL	$182.44 - $250.54 $3.49 Million - $4.8 Million	-19,153 Reduced 1.3%	1,449,529 $285 Million
Q2 2022 Aug 11, 2022	BUY	$204.13 - $302.4 $20.4 Million - $30.2 Million	99,739 Added 7.29%	1,468,682 $314 Million
Q1 2022 May 13, 2022	BUY	$255.51 - $362.11 $76.9 Million - $109 Million	301,159 Added 28.2%	1,368,943 $389 Million
Q4 2021 Feb 11, 2022	BUY	$351.38 - $448.68 $190 Million - $242 Million	540,217 Added 102.4%	1,067,784 $402 Million
Q3 2021 Nov 12, 2021	BUY	$372.64 - $458.3 $50.4 Million - $62 Million	135,189 Added 34.45%	527,567 $218 Million
Q2 2021 Aug 13, 2021	BUY	$294.17 - $371.65 $30.7 Million - $38.7 Million	104,250 Added 36.18%	392,378 $145 Million
Q1 2021 May 13, 2021	BUY	$249.67 - $299.48 $15.5 Million - $18.6 Million	62,023 Added 27.43%	288,128 $83.5 Million
Q4 2020 Feb 10, 2021	BUY	$222.0 - $252.62 $20.2 Million - $23 Million	90,937 Added 67.28%	226,105 $56.5 Million
Q3 2020 Nov 12, 2020	BUY	$175.56 - $226.45 $23.7 Million - $30.6 Million	135,168 New	135,168 $30.6 Million

Others Institutions Holding CRL

# of Institutions

695

Shares Held

52.2M

Call Options Held

259K

Put Options Held

463K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.45B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearbridge Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearbridge Investments, LLC with notifications on news.

Account

Clearbridge Investments, LLC Charles River Laboratories International, Inc. Transaction History